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Abstract
The objective of this research is to evaluate the commonly prescribed
treatment methods for prenatal and postnatal depression, focusing on the
efficacy of antidepressant medications and nonpharmacologic
treatments while evaluating the effects these medications have on the
fetus/breastfeeding infant.
The method of research included 15 studies completed with within the
past ten years on women who were pregnant or who had delivered a
baby within the past 12 months. One study did evaluate long-term
effects on offspring, which included a participant number of 3,342
children who were exposed to antidepressants during pregnancy. The
total number of participants in the studies were 8,069 women.
 Limitations within the data are due to small sample sizes in several of
the studies and few available studies that directly evaluate this
population of women and children.
Data results suggest that while cognitive group therapy does provide
depression symptom improvement in prenatal and postnatal depression
and anxiety, antidepressant medications tend to have a positive effect
earlier in treatment. Unfortunately, many of these antidepressant
medications have also been proven to have both short and long tern
effects on the offspring exposed to pharmacologic treatment.

Introduction
 First line treatment for severe or chronic major depression disorder in
adults: a referral to behavioral health in combination with
antidepressant therapy (National Guideline Clearinghouse, 2012).
Medication classes include: selective serotonin reuptake inhibitor
(SSRI), tricyclic antidepressants (TCA), serotonin-norepinephrine
reuptake inhibitor (SNRI), norepinephrine reuptake inhibitor (NRI),
and dopamine agonists (DA).
 Prevalence of Prenatal Depression: 6-13% (Charlton et al., 2014).
 Prevalence of Postpartum Depression: up to 20% (Van Lieshout et
al., 2017).

Statement of the Problem
One difficult area in the treatment of both depression and anxiety is in
the prenatal and breastfeeding patient population. Providers and patients
must work together to determine the best path of action for this unique
situation of caring for both the pregnant patient's mental health and her
unborn child.

Baseline Depression and Global Functioning of
Women With or Without Exposure to SSRI
Antidepressants
and Depression During Pregnancy
a Within each box, the white line represents the
median value. The
top and bottom edges of the box represent the 75th
and 25th percentiles,
respectively; these define the interquartile range.
Each bar
attached to the box represents 1.5 times the
interquartile range;
the filled circles are outliers.
b 29-item Structured Interview Guide for the
Hamilton Depression
Rating Scale With Atypical Depression Supplement
(29).
Wisner et al. (2009), page 561.

Research Questions
In the pregnant and breastfeeding population, what
is the efficacy of antidepressant medication treatment
for patients diagnosed with depression and/or
anxiety?
In pregnant patients diagnoses with depression
and/or anxiety, what are the fetal effects resulting
from use of antidepressants during pregnancy?
In breastfeeding patients diagnosed with depression
and/or anxiety, are there effects caused from the
transfer of antidepressant medications from mother
to infant during lactation?
In patients diagnosed with depression and/or anxiety
during pregnancy and postpartum, what is the
effectiveness of treatment options such as cognitive
behavioral health therapy?

Discussion
The literature review collectively found that both antidepressant
treatment and non-pharmacotherapy such as CBT are beneficial in
women suffering from depression and anxiety in the perinatal or
postpartum time. However, pharmacotherapy methods tend to
have a positive effect in a shorter amount of time when compared
to psychosocial therapies. Unfortunately, these antidepressant
medications have been shown to have a potentially negative
impact on the fetus during pregnancy. For the breastfeeding
infant, fluoxetine has been shown to be present in the serum of
exposed infants.

Sharp et al. (2010), page 45

Literature Review
 Depression symptoms are thought to be caused by a deficiency of
synaptic neurotransmitters such as serotonin, norepinephrine, and
dopamine (Bardal et al., 2011).
 Goals of antidepressant medication: improve the patient’s mood by
altering the neurotransmitter receptors and transporters to increase
the availability of the neurotransmitters within the synaptic cleft.
 Antidepressant Medication Efficacy
 Sharp et al. (2010) found that 45% of women receiving SSRI
treatment responded in 4 weeks compared to therapy sessions
in which only 20% improved after 4 weeks. At 18 weeks of
treatment, both medication and therapy responses were similar.
 Antidepressant Medication Effects on the Fetus
 Klieger-Grossman et al. (2012) found that infants exposed to
escitalopram (SSRI) had an increased risk of low birth weight
(9.9%) compared to other antidepressants (3.6%). Spontaneous
abortions were almost two times as common in antidepressant
medications (16%) when compared to controls (8.5%).
 Rai et al. (2017) found that 4.1% of children exposed to
antidepressants were diagnosed with autism, compared to
2.9% of children not exposed to medications.
 Antidepressant Medication Effects on the Breastfeeding Infant
 Weissman et al. (2004) found that fluoxetine had the highest
serum levels in breastfeeding infants (22%) compared to
paroxetine, nortriptyline, and sertraline.
 Non-pharmacotherapy treatment effectiveness
 Van Lieshout et al. (2017) found that group cognitive
behavioral therapy (CBT) showed statistical improvement of
depressive symptoms in 80% of women receiving treatment
over 9 weeks.
 A Cochrane Review found shat interpersonal psychotherapy
had increased improvement rates when compared to parenting
education programs (Dennis et al., 2007).

Applicability to Clinical
Practice
 The standard practice guidelines for treatment and management
of adult depression and anxiety include both cognitive behavioral
therapy (CBT) and antidepressant medications.
The research gathered in this literature review do suggest that
antidepressant medications tend to have a quicker response rate for
improvement of symptoms when compared to psychosocial
therapies. CBT does show symptom improvement as well, but
tends to take more sessions to reach the same improvement rate as
medication therapy.
Unfortunately, there continues to be research showing that the
commonly-used antidepressant medications have effects on
offspring. During pregnancy, spontaneous abortions are more
common across all antidepressant medication classes. Smaller
birth weight and earlier delivery rates are associated with women
who have taken antidepressant medications.
Although not studied thoroughly, antidepressant metabolites have
been shown to appear in the serum of lactating infants exposed to
antidepressants.
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